OptiBrand Rx is passionate about creating great, strategic and confusion-free brand names.  Recent guidance from Health Canada makes Look-Alike & Sound-Alike Assessment (LASA) essential for all brand name submissions in Canada.

OBRx vets brand name candidates throughout the creative process to avoid LASA issues.  This results in a higher yield of strategically-acceptable name candidates with low potential for confusion and patient harm.

Our disciplined due diligence includes a multifactorial process that meets the strict trademark, linguistic and regulatory standards of Health Canada and evaluates name candidates commercially in each market as well.

Our protocol is purpose-built to comply with the special Health Canada requirements enacted in July 2015.
(Read more about the Health Canada Guidance here)